![Data-driven identification of heart failure disease states and progression pathways using electronic health records | Scientific Reports Data-driven identification of heart failure disease states and progression pathways using electronic health records | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22398-4/MediaObjects/41598_2022_22398_Fig1_HTML.png)
Data-driven identification of heart failure disease states and progression pathways using electronic health records | Scientific Reports
![Pharmacoepidemiology | Free Full-Text | Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure Pharmacoepidemiology | Free Full-Text | Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure](https://www.mdpi.com/pharmacoepidemiology/pharmacoepidemiology-01-00009/article_deploy/html/images/pharmacoepidemiology-01-00009-g001.png)
Pharmacoepidemiology | Free Full-Text | Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure
![Abstract 14199: Defining Phenotypic Representativeness of the TOPCAT Trial to a Real-World Electronic Health Record Using Multidimensional Phenomaps | Circulation Abstract 14199: Defining Phenotypic Representativeness of the TOPCAT Trial to a Real-World Electronic Health Record Using Multidimensional Phenomaps | Circulation](https://www.ahajournals.org/cms/asset/ce8acf72-85b8-4cf3-a850-740e0959a119/g14199.jpg)
Abstract 14199: Defining Phenotypic Representativeness of the TOPCAT Trial to a Real-World Electronic Health Record Using Multidimensional Phenomaps | Circulation
![Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation](https://www.ahajournals.org/cms/asset/ee723c25-9e17-4d89-9603-243a0a3b3888/34fig01.jpeg)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation
![Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177917300434-fx1.jpg)
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect
![Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries - Journal of Cardiac Failure Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries - Journal of Cardiac Failure](https://www.onlinejcf.com/cms/asset/3f45bb32-024d-4462-912c-bcb42a08270e/gr1.jpg)
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries - Journal of Cardiac Failure
![Heart failure (HF) hospitalisation across 6 major phase 3 trials of... | Download Scientific Diagram Heart failure (HF) hospitalisation across 6 major phase 3 trials of... | Download Scientific Diagram](https://www.researchgate.net/publication/322334940/figure/fig1/AS:580882550931456@1515504600769/Heart-failure-HF-hospitalisation-across-6-major-phase-3-trials-of-pharmacologic-therapy.png)
Heart failure (HF) hospitalisation across 6 major phase 3 trials of... | Download Scientific Diagram
![Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/82a89083-68c3-4c8b-b0c5-7b352140ef5b/ejhf442-fig-0001-m.jpg)
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library
![Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study | JACC: Heart Failure Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study | JACC: Heart Failure](https://www.jacc.org/cms/asset/a979d2b9-979a-4c8a-aaff-c00fc266e659/fx1.jpg)
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study | JACC: Heart Failure
![Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177918303718-gr1.jpg)
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect
![Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation](https://www.ahajournals.org/cms/asset/199097bb-c29e-4902-a97a-168febccb5cf/34fig02.jpeg)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation
![Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109721000140-fx1.jpg)
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function - ScienceDirect
![Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure](https://www.onlinejcf.com/cms/asset/ffe16d7d-fcb7-4312-b976-4cf3ee3bf261/gr1.jpg)
Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Manual of Operations
![Kaplan-Meier curves for all-cause mortality according to clinical trial... | Download Scientific Diagram Kaplan-Meier curves for all-cause mortality according to clinical trial... | Download Scientific Diagram](https://www.researchgate.net/publication/337604461/figure/fig1/AS:832070578343943@1575392493924/Kaplan-Meier-curves-for-all-cause-mortality-according-to-clinical-trial-and-New-York.png)
Kaplan-Meier curves for all-cause mortality according to clinical trial... | Download Scientific Diagram
![Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2452302X16000346-gr3.jpg)
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
![Frontiers | Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis Frontiers | Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/854501/854501_Thumb_400.jpg)
Frontiers | Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
![Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction | Hypertension Research Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-022-01079-9/MediaObjects/41440_2022_1079_Figa_HTML.png)
Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction | Hypertension Research
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Protocols
![Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1183c4e6-a0a3-4360-b91d-47dfeb2bbcee/ehf214068-fig-0005-m.jpg)
Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library
![Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b55d8232-fd2d-4bb1-b500-979030cd234d/ehf214068-fig-0004-m.jpg)